Moderna’s COVID-19 Vaccine Protective, Safe in Young Children

Published on October 25, 2021

Moderna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, citing interim data from a study. The company said it planned to submit the data to U.S., European and other regulators…

Read Full Article (External Site)